Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Dec;74(6):1105-11.
doi: 10.1007/s00280-014-2559-9. Epub 2014 Aug 19.

MicroRNAs: A New Key in Lung Cancer

Affiliations
Review

MicroRNAs: A New Key in Lung Cancer

Yunlong Zhang et al. Cancer Chemother Pharmacol. .

Abstract

Lung cancer as a malignance has been killing numerous patients around the world annually, and small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) are the two major types, the later accounting for nearly 80 % of lung cancer. There are multiple causes for lung cancer, and more researches have been carried out to prevent, anticipate, and diagnose the cancer. MicroRNAs (miRNAs) are small non-coding RNA molecules capable of regulating expression of over 50 % of protein-coding genes. The RNA molecules are stable in tissues and blood, so it can tend to be a biomarker in anti-lung cancer. Here, this is a review on the roles of miRNAs for possible ways to prevent lung cancer in clinical trials.

Similar articles

See all similar articles

Cited by 26 articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources

Feedback